(2006). Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
(2008). Bernal-Mizrachi E: Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner.
(2005). Bluestone JA: A single course of anti-CD3 monoclonal antibody hOKT3 results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54:1763–1769,
(2007). Bluestone JA: CD3-speciﬁc antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol 7:622–632,
(2008). Bluestone JA: Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687–697,
(2005). Bluestone JA: The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447–485,
(2003). CD3-speciﬁc antibody-induced active tolerance: from bench to bedside. Nat Rev Immunol 3:123–132,
(2005). Chatenoud L: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
(2003). Chatenoud L: TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9:1202–1208,
(2002). Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes 51:638– 645,
(2006). Contag CH, Negrin RS: Inhibition of CD4CD25 regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108:390–399,
(2008). de Casteele M: Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR. Biochem Pharmacol 75:1981–1993,
(2009). G: mTOR inhibition by rapamycin prevents -cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945–957,
(2006). IJ: Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells. Transplantation 81:445–454,
(1994). JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.